Mondelez International stock analysis for 2026: Oreo, Cadbury, Ritz brand portfolio, the direct GLP-1 threat to snack demand, Clif Bar and Ricolino acquisition impacts, cocoa cost pressure, and emerging market growth as the offsetting thesis.
Coca-Cola stock analysis for 2026 covering its 62-year dividend streak, GLP-1 weight-loss drug threats to beverage demand, asset-light bottling model, segment breakdown, and Roth IRA suitability for US income investors.
Procter & Gamble stock analysis for 2026 covering its 67+ year dividend streak, GLP-1 weight-loss drug implications for consumer staples, FY2024 financials, and Roth IRA suitability.
A thorough analysis of DIVO, Amplify's actively managed blue-chip dividend ETF with a tactical covered-call overlay: how Capital Wealth Planning selects 25-30 stocks, manages the 5-15% call overlay, handles ROC distributions, and how it compares to SCHD, JEPI, and QYLD for income investors.
A deep dive into Fidelity's FDVV ETF: how the three-factor index blends dividend yield, dividend growth, and payout consistency across ~100 stocks, its 0.16% expense ratio, tech-inclusive holdings, and where it fits alongside HDV, SCHD, and VYM in an income portfolio.
A thorough analysis of BlackRock's HDV ETF: Morningstar Dividend Yield Focus Index methodology, 0.08% expense ratio, energy-heavy portfolio, qualified dividends, and how to position it in a taxable account or IRA alongside SCHD and VYM.